Shin-Etsu Chemical to Build New Cellulose Plant in Germany (Japan)
This article was originally published in PharmAsia News
Executive Summary
Japan-based Shin-Etsu Chemical Co. announced it will start construction of a new manufacturing facility in Germany. The new facility will focus on producing cellulose for use in pharmaceuticals and other medical-ventures. Shin-Etsu also plans to improve production of medical-use cellulose in its central Japan facility. As a whole, cellulose production by the company will increase to around 70,000 tons a year, up from current manufacturing rates of 63,000 tons. (Click here for more
You may also be interested in...
Executives On The Move: Changes At The Top At Enzolytics, Dyne Therapeutics And Seres Therapeutics
Recent moves in the industry include new chief financial officers at LENZ Therapeutics and Botanix Pharmaceuticals, plus new chief medical officers at Vigil Neuroscience and Voyager Therapeutics.
Israel's Gamida Cell Survives By Selling To Lender
Having finally secured US approval for Omisirge, Gamida was hoping to bag a strategic partner for the cell therapy. A year on, no suitable partner has been identified and the firm is delisting from the NASDAQ and going private.
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.